GUNA-COUGH

Manufacturer: Guna spa
Effective date: 2020-10-23
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 02:13:26

Label at a glance#

ProductGUNA-COUGH

Active ingredientALTHAEA OFFICINALIS LEAF, ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, CETRARIA ISLANDICA SUBSP. ISLANDICA, COCHINEAL, COPPER, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, PLANTAGO MAJOR, LOBARIA PULMONARIA, THYME

Label structure10 sections

Indications and uses

Relieves dry and wet cough Helps reduce mucus and phlegm

Dosage and administration

Use enclosed dosage cup for dosing Adults and children 12 years and older 10 ml every 4 hours as needed Children between 12 years and 2 years of age 5 ml every 4 hours as needed Children under 2 years Ask a physician

Contacts and useful links#

PhoneLabel contact(484) 223-3500

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS/PURPOSE

OTC - ACTIVE INGREDIENT SECTION

ALTHAEA OFFICINALIS 1X SOOTHING

ANTIMONIUM TARTARICUM 8X EXPECTORANT

CETRARIA ISLANDICA 4X EXPECTORANT

COCCUS CACTI 6X RELIEVES COUGH

PLANTAGO MAJOR 1X RELIEVES SORE THROAT

BRYONIA 6X RELIEVES DRY COUGH

CUPRUM ACETICUM 8X RELIEVES COUGH

DROSERA 1X RELIEVES DRY COUGH

ECHINACEA 1X SOOTHING

STICTA PULMONARIA 4X EXPECTORANT

THYME 1X SOOTHING

USES

OTC - PURPOSE SECTION

Relieves dry and wet cough
Helps reduce mucus and phlegm

WARNINGS

WARNINGS SECTION

Ask a doctor before use if you have a persistent or chronic cough that lasts, is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema or is accompanied by excessive phlegm (mucus).

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
If pregnant or breast-feeding ask a health care professional before use.
Keep out of reach of children.
In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately

PREGNANCY

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding ask a doctor before use

WARNINGS

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Use enclosed dosage cup for dosing

Adults and children 12 years and older 10 ml every 4 hours as needed

Children between 12 years and 2 years of age 5 ml every 4 hours as needed

Children under 2 years Ask a physician

QUESTIONS

OTC - QUESTIONS SECTION

Questions?: info@gunainc.com
Tel. (484) 223-3500

INDICATIONS & USAGE SECTION

Directions: use enclosed cup for dosing.

INACTIVE INGREDIENT SECTION

Inactive ingredients: purified water, fructose syrup, hydroxypropyl methylcellulose, potassium sorbate, sodium benzoate, cherry flavor.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

5USOMT

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c599c4a0-705d-4ebb-ab1f-977af038f96a	Product name	1	20251124

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17089-453-24	2020-03-13	C162847	48780-1	9d75b9d0-485b-f424-e053-dadaa90a57ce	GUNA-COUGH
17089-453-24	2020-01-31	C162847	48780-1	9d75b9d0-485b-f424-e053-dadaa90a57ce	GUNA-COUGH

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17089-453-24	GUNA-COUGH	150 mL in 1 BOTTLE	SOLUTION/ DROPS	150		7
17089-453-24	GUNA-COUGH	1 in 1 BOX	SOLUTION/ DROPS	1		7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17089-453	GUNA-COUGH (ALTHAEA OFFICINALIS LEAF - ANTIMONY POTASSIUM TARTRATE - BRYONIA ALBA ROOT - CETRARIA ISLANDICA SUBSP. ISLANDICA - COCHINEAL - COPPER - DROSERA ROTUNDIFOLIA - ECHINACEA ANGUSTIFOLIA - GARDEN THYME - LOBARIA PULMONARIA - PLANTAGO MAJOR -) SOLUTION/ DROPS [GUNA SPA]	7	Current NDC, Legacy NDC, 2 package rows	20201024_40e9509c-5cc2-4077-ab89-34bec9015f42.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALTHAEA OFFICINALIS LEAF	ACTIVE INGREDIENT	E2QQV92338	1
ANTIMONY POTASSIUM TARTRATE	ACTIVE INGREDIENT	DL6OZ476V3	1
BRYONIA ALBA ROOT	ACTIVE INGREDIENT	T7J046YI2B	1
CETRARIA ISLANDICA SUBSP. ISLANDICA	ACTIVE INGREDIENT	BJ7YPN79A1	1
COCHINEAL	ACTIVE INGREDIENT	TZ8Z31B35M	1
COPPER	ACTIVE INGREDIENT	789U1901C5	1
DROSERA ROTUNDIFOLIA	ACTIVE INGREDIENT	75O014T1HG	1
ECHINACEA ANGUSTIFOLIA	ACTIVE INGREDIENT	VB06AV5US8	1
LOBARIA PULMONARIA	ACTIVE INGREDIENT	D1YM0P5Z2T	1
PLANTAGO MAJOR	ACTIVE INGREDIENT	W2469WNO6U	1
THYME	ACTIVE INGREDIENT	CW657OBU4N	1
ALTHAEA OFFICINALIS LEAF	ACTIVE MOIETY	E2QQV92338	1
BRYONIA ALBA ROOT	ACTIVE MOIETY	T7J046YI2B	1
CETRARIA ISLANDICA SUBSP. ISLANDICA	ACTIVE MOIETY	BJ7YPN79A1	1
COCHINEAL	ACTIVE MOIETY	TZ8Z31B35M	1
COPPER	ACTIVE MOIETY	789U1901C5	1
DROSERA ROTUNDIFOLIA	ACTIVE MOIETY	75O014T1HG	1
ECHINACEA ANGUSTIFOLIA	ACTIVE MOIETY	VB06AV5US8	1
LOBARIA PULMONARIA	ACTIVE MOIETY	D1YM0P5Z2T	1
PLANTAGO MAJOR	ACTIVE MOIETY	W2469WNO6U	1
TARTARIC ACID	ACTIVE MOIETY	W4888I119H	1
THYME	ACTIVE MOIETY	CW657OBU4N	1
FRUCTOSE	INACTIVE INGREDIENT	6YSS42VSEV	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	1
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

GUNA-COUGH
ALTHAEA OFFICINALIS LEAF - ANTIMONY POTASSIUM TARTRATE - BRYONIA ALBA ROOT - CETRARIA ISLANDICA SUBSP. ISLANDICA - COCHINEAL - COPPER - DROSERA ROTUNDIFOLIA - ECHINACEA ANGUSTIFOLIA - GARDEN THYME - LOBARIA PULMONARIA - PLANTAGO MAJOR -
FRUCTOSE
HYPROMELLOSES
POTASSIUM SORBATE
SODIUM BENZOATE
ALTHAEA OFFICINALIS LEAF
ANTIMONY POTASSIUM TARTRATE
ANTIMONY CATION (3+)
BRYONIA ALBA ROOT
CETRARIA ISLANDICA SUBSP. ISLANDICA
COCHINEAL
COPPER
DROSERA ROTUNDIFOLIA
ECHINACEA ANGUSTIFOLIA
PLANTAGO MAJOR
LOBARIA PULMONARIA
THYME

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17089-453	17089-453-24

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
FRUCTOSE	6YSS42VSEV	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
POTASSIUM SORBATE	1VPU26JZZ4	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
ALTHAEA OFFICINALIS LEAF	E2QQV92338	ACTIB
ANTIMONY POTASSIUM TARTRATE	DL6OZ476V3	ACTIB
BRYONIA ALBA ROOT	T7J046YI2B	ACTIB
CETRARIA ISLANDICA SUBSP. ISLANDICA	BJ7YPN79A1	ACTIB
COCHINEAL	TZ8Z31B35M	ACTIB
COPPER	789U1901C5	ACTIB
DROSERA ROTUNDIFOLIA	75O014T1HG	ACTIB
ECHINACEA ANGUSTIFOLIA	VB06AV5US8	ACTIB
PLANTAGO MAJOR	W2469WNO6U	ACTIB
LOBARIA PULMONARIA	D1YM0P5Z2T	ACTIB
THYME	CW657OBU4N	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 114 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, EXTENDED RELEASE / ORAL	0.2 mg		Exact identifier — unii+route 26 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, COATED / ORAL	0.2 mg		Exact identifier — unii+route 38 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	POWDER, FOR SUSPENSION / ORAL		19 mg	Exact identifier — unii+route 26 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 16 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	CONCENTRATE / ORAL		1 mg	Exact identifier — unii+route 26 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SUSPENSION / ORAL	20 mg/1ml		Exact identifier — unii+route 16 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE, DELAYED RELEASE / ORAL		105 mg	Exact identifier — unii+route 34 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	CONCENTRATE / ORAL		1 mg	Exact identifier — unii+route 26 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL		1127 mg	Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	ELIXIR / ORAL	5.02 mg/5ml		Exact identifier — unii+route 38 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION / ORAL		320 mg	Exact identifier — unii+route 38 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	POWDER, FOR SUSPENSION / ORAL		6000 mg	Exact identifier — unii+route 16 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, COATED / ORAL	NA		Exact identifier — unii+route 26 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	TABLET / ORAL	64.92 mg		Exact identifier — unii+route 16 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, EFFERVESCENT / ORAL	60 mg		Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE / ORAL		1488 mg	Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SYRUP / ORAL		80 mg	Exact identifier — unii+route 38 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	ELIXIR / ORAL	5.02 mg/5ml		Exact identifier — unii+route 38 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	SYRUP / ORAL	2 mg/1ml		Exact identifier — unii+route 26 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET / ORAL	30 mg		Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, FILM COATED / ORAL		582 mg	Exact identifier — unii+route 34 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	SYRUP / ORAL		250 mg	Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION, EXTENDED RELEASE / ORAL		24 mg	Exact identifier — unii+route 38 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SYRUP / ORAL	1732.5 mg/5ml		Exact identifier — unii+route 16 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE, DELAYED RELEASE / ORAL		105 mg	Exact identifier — unii+route 34 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL		1127 mg	Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	PASTE / ORAL		28 mg	Exact identifier — unii+route 38 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	CONCENTRATE / ORAL		20 mg	Exact identifier — unii+route 38 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	POWDER, FOR SOLUTION / ORAL		98 mg	Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, EXTENDED RELEASE / ORAL		1472 mg	Exact identifier — unii+route 34 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, COATED / ORAL	NA		Exact identifier — unii+route 26 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, COATED / ORAL		58 mg	Exact identifier — unii+route 34 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SUSPENSION / ORAL	20 mg/1ml		Exact identifier — unii+route 16 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	CAPSULE / ORAL	8.5 mg		Exact identifier — unii+route 38 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii+route 38 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	CAPSULE / ORAL	NA		Exact identifier — unii+route 26 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	GRANULE, FOR SUSPENSION / ORAL		80 mg	Exact identifier — unii+route 26 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET / ORAL		6 mg	Exact identifier — unii+route 26 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, DELAYED RELEASE / ORAL	0.34 mg		Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	SYRUP / ORAL		250 mg	Exact identifier — unii+route 34 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	0.2 mg		Exact identifier — unii+route 26 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	CONCENTRATE / ORAL		20 mg	Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED PELLETS / ORAL	3.32 mg		Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	CAPSULE / ORAL	8.5 mg		Exact identifier — unii+route 38 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	0.2 mg		Exact identifier — unii+route 26 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	PASTE / ORAL		48 mg	Exact identifier — unii+route 26 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	GRANULE, FOR SUSPENSION / ORAL	1.7 mg		Exact identifier — unii+route 34 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, ORALLY DISINTEGRATING / ORAL		41 mg	Exact identifier — unii+route 34 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	GRANULE / ORAL		45 mg	Exact identifier — unii+route 34 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 16 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, COATED / ORAL		58 mg	Exact identifier — unii+route 34 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 26 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, EXTENDED RELEASE / ORAL		1472 mg	Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, EFFERVESCENT / ORAL	60 mg		Exact identifier — unii+route 38 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE, EXTENDED RELEASE / ORAL	119.7 mg		Exact identifier — unii+route 34 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	TABLET, ORALLY DISINTEGRATING / ORAL		41 mg	Exact identifier — unii+route 34 equally ranked IID candidates
FRUCTOSE	FRUCTOSE	6YSS42VSEV	SYRUP / ORAL	1732.5 mg/5ml		Exact identifier — unii+route 16 equally ranked IID candidates
HYPROMELLOSE	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 34 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION/ DROPS / ORAL		23 mg	Exact identifier — unii+route 38 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GUNA-COUGH	ALTHAEA OFFICINALIS LEAF - ANTIMONY POTASSIUM TARTRATE - BRYONIA ALBA ROOT - CETRARIA ISLANDICA SUBSP. ISLANDICA - COCHINEAL - COPPER - DROSERA ROTUNDIFOLIA - ECHINACEA ANGUSTIFOLIA - GARDEN THYME - LOBARIA PULMONARIA - PLANTAGO MAJOR -	Guna spa	40e9509c-5cc2-4077-ab89-34bec9015f42	2020-10-23	Warnings	Exact identifier ndc (package): 17089-453-24 ndc (product): 17089-453 ndc11 (package): 17089045324 spl id: b2576e8c-11d8-1d15-e053-2a95a90a72b1 spl set id: 40e9509c-5cc2-4077-ab89-34bec9015f42

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.